NTI Launches NTI | bio Advisory Group

NTI’s recently expanded Global Biological Policy and Programs (NTI | bio) is launching a high-level advisory group this week.  The group—chaired by former commissioner of the Food and Drug Administration Margaret Hamburg, M.D., an NTI board member who now serves as foreign secretary of the National Academy of Medicine—will provide strategic guidance on the program’s effort to reduce global biological risks.

Advisory group members include:

  • John Brownstein, Ph.D., Chief Innovation Officer, Boston Children’s Hospital
  • R. Alta Charo, Ph.D., J.D., Warren P. Knowles Professor of Law and Bioethics, University of Wisconsin
  • Gerald R. Fink, Ph.D., Member, Whitehead Institute, Professor of Genetics, MIT
  • Tore Godal, M.D., Ph.D., Special Advisor on Global Health, Ministry of Foreign Affairs, Norway
  • Avril Haines, J.D., Senior Research Scholar, Columbia University, former Deputy National Security Advisor to President Barack Obama
  • Jeremy Konyndyk, MSFS, Senior Policy Fellow, Center for Global Development, former Director of the USAID Office of Foreign Disaster Assistance
  • John Nkengasong, Ph.D., Director, Africa Centres for Disease Control and Prevention
  • David A. Relman, M.D., Stanford University, Co-director of the Center for International Security and Cooperation
  • Reshma Shetty, Ph.D., Co-Founder, Ginkgo Bioworks
  • Dr John-Erik Stig Hansen, M.D., DMSc, Director of the Centre for Biosecurity and Biopreparedness, Denmark
  • Renee Wegrzyn, Ph.D., Program Manager, Biological Technologies Office (BTO), Defense Advanced Research Projects Agency (DARPA).

The inaugural meeting of the NTI | bio Advisory Group will be held at NTI’s offices on Thursday, June 14.  

“We deeply appreciate the time, expertise, and confidence that this esteemed group is giving us, as NTI expands our biosecurity initiative,” said NTI Co-chair and CEO Ernest J. Moniz. “We look forward to working together on the steps required to reduce biological risks and improve global health security.”  

NTI has addressed biosecurity issues since its founding in 2001. Last year, NTI | bio initiated a significant expansion, thanks to generous support from the Open Philanthropy Project,  which is allowing NTI to develop new initiatives to curb global catastrophic biological risks, catalyze international biosecurity norms and innovation, enhance biosurveillance for emerging threats, and advocate for measurable biosecurity commitments as an integral component of the Global Health Security Agenda (GHSA). The GHSA is a partnership of nearly 50 states, international organizations, and NGOs to help create a world safe from infectious disease threats and to bring together nations to make new, concrete commitments, and to elevate global health security as a national leaders-level priority. NTI | bio is led by Elizabeth Cameron, Ph.D., vice president for Global Biological Policy and Programs.

NTI works to protect our lives, environment, and quality of life now and for future generations. We work to prevent catastrophic attacks with weapons of mass destruction and disruption (WMDD)—nuclear, biological, radiological, chemical, and cyber. Founded in 2001 by former U.S. Senator Sam Nunn and philanthropist Ted Turner who continue to serve as co-chairs, NTI is guided by a prestigious, international board of directors. Ernest J. Moniz serves as chief executive officer and co-chair; Des Browne is vice chair; and Joan Rohlfing serves as president.


June 13, 2018

NTI’s recently expanded Global Biological Policy and Programs (NTI | bio) is launching a high-level advisory group this week.